Immix Biopharma (IMMX) Shares Outstanding (Diluted) (2022 - 2026)
Immix Biopharma (IMMX) reported Shares Outstanding (Diluted) of 63.77 million for Q2 2026, up 112.7% from 29.98 million a year earlier and up 15.2% from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
For FY2025, Immix Biopharma posted Shares Outstanding (Diluted) of 32.97 million, up 16.5% from FY2024.
- Shares Outstanding (Diluted) has increased for three consecutive years, with a three-year compound annual growth rate of 33.4% (FY2022 to FY2025).
- By year, Shares Outstanding (Diluted) came in at 28.29 million in FY2024 (+63.1%), 17.34 million in FY2023 (+24.9%) and 13.89 million in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Diluted) in data going back to Q2 2022.
- Year over year, Shares Outstanding (Diluted) has now increased in each of the last 13 quarters, with growth averaging 47.1% over the last eight quarters.
- The year-over-year growth in Shares Outstanding (Diluted) has ranged between 4.2% (Q2 2025) and 112.7% (Q2 2026) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at 55.37 million (Q1 2026), 32.97 million (Q4 2025) and 31.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Immix Biopharma | 597.32 Mn | 365.22 Mn | - | 63.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.77 Mn |
| Mar 31, 2026 | 55.37 Mn |
| Dec 31, 2025 | 32.97 Mn |
| Sep 30, 2025 | 31.93 Mn |
| Jun 30, 2025 | 29.98 Mn |
| Mar 31, 2025 | 29.70 Mn |
| Dec 31, 2024 | 28.29 Mn |
| Sep 30, 2024 | 29.42 Mn |
| Jun 30, 2024 | 28.79 Mn |
| Mar 31, 2024 | 23.44 Mn |
| Dec 31, 2023 | 17.34 Mn |
| Sep 30, 2023 | 18.58 Mn |
| Jun 30, 2023 | 15.04 Mn |
| Mar 31, 2023 | 13.90 Mn |
| Dec 31, 2022 | 13.89 Mn |
| Sep 30, 2022 | 13.92 Mn |
| Jun 30, 2022 | 13.88 Mn |
API Access
Immix Biopharma Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();